stockrowBaxter International Inc.
BAX Healthcare Medical Instruments & Supplies
Baxter International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.2 billion, up 5.72% from fiscal 2024.
- Revenue
- +4.97%
- EPS
- +731.9%
- Free cash flow
- +255.6%
- Total debt
- −9.48%
Quarter to September 2026, against a year earlier
Follow BAX
Alert me
Baxter International Inc. (BAX) Net income
Baxter International Inc.'s net income for fiscal 2025 was −$957.0M, compared with −$638.0M in fiscal 2024. Over the twelve months to 30 September 2026 it was −$723.0M. Over the past ten years it has ranged from −$2.4B (fiscal 2022) to $5.0B (fiscal 2016); the current reading is higher than 18% of that period. Baxter International Inc. ranks 50th of 51 Medical Instruments & Supplies companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | −$957.0M | — |
| FY2024 | −$638.0M | — |
| FY2023 | $2.7B | — |
| FY2022 | −$2.4B | — |
| FY2021 | $1.3B | 16.67% |
| FY2020 | $1.1B | 9.79% |
| FY2019 | $1.0B | (34.61%) |
| FY2018 | $1.5B | 156.81% |
| FY2017 | $602.0M | (87.88%) |
| FY2016 | $5.0B | 412.91% |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $294.0M | 133.33% |
| Jun 2026 | $126.0M | — |
| Mar 2026 | −$15.0M | — |
| Dec 2025 | −$1.1B | — |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| WST West Pharmaceutical Services, Inc. compare | $638.9M |
| COO The Cooper Companies, Inc. compare | $570.3M |
| ALGN Align Technology, Inc. compare | $413.6M |
| AVTR Avantor, Inc. compare | $337.2M |
| ATR AptarGroup, Inc. compare | $267.9M |
| SOLV Solventum Corporation compare | $156.0M |
| RGEN Repligen Corporation compare | −$11.8M |
| BLCO Bausch + Lomb Corporation compare | −$103.0M |
| BAX Baxter International Inc. | −$723.0M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on BAX
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement